BRPI0612424A2 - composiÇÕes e mÉtodos para tratar condiÇÕes relacionadas com a sinalizaÇço da efrina com cupredoxinas - Google Patents
composiÇÕes e mÉtodos para tratar condiÇÕes relacionadas com a sinalizaÇço da efrina com cupredoxinasInfo
- Publication number
- BRPI0612424A2 BRPI0612424A2 BRPI0612424-0A BRPI0612424A BRPI0612424A2 BR PI0612424 A2 BRPI0612424 A2 BR PI0612424A2 BR PI0612424 A BRPI0612424 A BR PI0612424A BR PI0612424 A2 BRPI0612424 A2 BR PI0612424A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- compositions
- cupredoxins
- signaling
- ephrine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
COMPOSIÇÕES E MÉTODOS PARA TRATAR CONDIÇÕES RELACIONADAS COM A SINALIZAÇçO DA EFRINA COM CUPREDOXINAS. Mais particularmente a composições e métodos do uso de cupredoxinas, suas variantes, derivadas e equivalentes estruturais que interferem no sistema de sinalização da efrina em células de mamíferos. Especificamente, a invenção diz respeito a composições e métodos que usam as cupredoxinas, tais como azurina, rusticianina e plastocianina, bem como suas variantes, derivadas e equivalentes estruturais, para tratar o câncer em mamíferos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68281205P | 2005-05-20 | 2005-05-20 | |
US11/244,105 US7691383B2 (en) | 2004-10-07 | 2005-10-06 | Cupredoxin derived transport agents and methods of use thereof |
US76474906P | 2006-02-03 | 2006-02-03 | |
PCT/US2006/019684 WO2007018671A2 (en) | 2005-05-20 | 2006-05-19 | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0612424A2 true BRPI0612424A2 (pt) | 2009-01-27 |
Family
ID=37727776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0612424-0A BRPI0612424A2 (pt) | 2005-05-20 | 2006-05-19 | composiÇÕes e mÉtodos para tratar condiÇÕes relacionadas com a sinalizaÇço da efrina com cupredoxinas |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1888106A4 (pt) |
JP (1) | JP2008539795A (pt) |
KR (1) | KR20080040631A (pt) |
AU (1) | AU2006277009A1 (pt) |
BR (1) | BRPI0612424A2 (pt) |
CA (1) | CA2608512A1 (pt) |
IL (1) | IL187138A0 (pt) |
MX (1) | MX2007014598A (pt) |
NO (1) | NO20076391L (pt) |
WO (1) | WO2007018671A2 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
AU2005327535A1 (en) | 2004-10-07 | 2006-08-24 | Ananda Chakrabarty | Cupredoxin derived transport agents and methods of use thereof |
AU2006284490A1 (en) * | 2005-07-19 | 2007-03-01 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to control angiogenesis with cupredoxins |
WO2007012004A2 (en) | 2005-07-19 | 2007-01-25 | The Board Of Trustees Of The University Of Illinois | Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
CN101595124A (zh) * | 2006-09-14 | 2009-12-02 | 伊利诺斯大学理事会 | 使用铜氧还蛋白预防癌症的组合物及方法 |
EP2117573A4 (en) * | 2007-01-11 | 2011-02-16 | Univ Illinois | COMPOSITIONS AND METHODS FOR TREATING EPHRIN SIGNALING WITH CUPREDOXINES AND MUTANTS THEREOF |
TWI443109B (zh) | 2007-08-30 | 2014-07-01 | Daiichi Sankyo Co Ltd | 抗epha2抗體 |
KR101102829B1 (ko) * | 2008-09-12 | 2012-01-05 | 재단법인 제주테크노파크 | 구멍갈파래 추출물과 그것의 항염증제로서의 용도 |
CN110090295B (zh) * | 2018-01-29 | 2022-12-23 | 武汉康理通科技有限公司 | Ephrin-B1在制备治疗炎症性肠病的药物中的用途 |
WO2023205752A2 (en) * | 2022-04-22 | 2023-10-26 | University Of Miami | Ephrin ligand mimetic peptides for the treatment of neurodegenerative diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2436224A1 (en) * | 2001-02-15 | 2002-10-03 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
-
2006
- 2006-05-19 JP JP2008512587A patent/JP2008539795A/ja active Pending
- 2006-05-19 EP EP06813192A patent/EP1888106A4/en not_active Withdrawn
- 2006-05-19 KR KR1020077028984A patent/KR20080040631A/ko not_active Application Discontinuation
- 2006-05-19 WO PCT/US2006/019684 patent/WO2007018671A2/en active Application Filing
- 2006-05-19 CA CA002608512A patent/CA2608512A1/en not_active Abandoned
- 2006-05-19 MX MX2007014598A patent/MX2007014598A/es active IP Right Grant
- 2006-05-19 BR BRPI0612424-0A patent/BRPI0612424A2/pt not_active IP Right Cessation
- 2006-05-19 AU AU2006277009A patent/AU2006277009A1/en not_active Abandoned
-
2007
- 2007-11-04 IL IL187138A patent/IL187138A0/en unknown
- 2007-12-11 NO NO20076391A patent/NO20076391L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2608512A1 (en) | 2007-02-15 |
NO20076391L (no) | 2008-02-15 |
AU2006277009A1 (en) | 2007-02-15 |
JP2008539795A (ja) | 2008-11-20 |
WO2007018671A3 (en) | 2007-11-22 |
EP1888106A2 (en) | 2008-02-20 |
MX2007014598A (es) | 2008-02-07 |
WO2007018671A2 (en) | 2007-02-15 |
EP1888106A4 (en) | 2009-01-14 |
IL187138A0 (en) | 2008-02-09 |
KR20080040631A (ko) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0612424A2 (pt) | composiÇÕes e mÉtodos para tratar condiÇÕes relacionadas com a sinalizaÇço da efrina com cupredoxinas | |
NL301145I2 (nl) | Tirbanibulin | |
MX360301B (es) | Moleculas pequeñas que contienen boro como agentes antiinflamatorios. | |
EA201791850A1 (ru) | Борсодержащие малые молекулы | |
SG170813A1 (en) | New compounds | |
EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
BRPI0808775A2 (pt) | compostos e composições como moduladores de atividade de gpr119 | |
MX2009004047A (es) | Compuestos organicos. | |
BR112012010820A2 (pt) | octa-hidropirrolo[3,4-c]pirróis dissubstituídos como moduladores do receptor de orexina | |
EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
CL2010001637A1 (es) | Compuestos derivados de isoindolonas; composición farmacéutica que los comprende; y su uso como inhibidores de la quinasa mek para tratar enfermedades hiperproliferativas y/o inflamatorias tales como cáncer, artritis reumatoidea entre otras. | |
BR112012010270A2 (pt) | mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
TN2010000096A1 (en) | Oxadiazole - and oxazole - substituted benzimidazole - and indole - derivatives as dgat1 inhibitors | |
MX2007012237A (es) | Amilina y agonistas de amilina para tratar enfermedades y trastornos siquiatricos. | |
EA201001456A1 (ru) | Новые гетероциклические соединения и их применение | |
MX2009011025A (es) | Compuestos con actividad anticancer. | |
BRPI0923786C8 (pt) | compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos | |
WO2010031056A3 (en) | Methods and compositions for modulating ire1, src, and abl activity | |
EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
UA99839C2 (ru) | Бензодиазепиноновые соединения, применяемые при лечении кожных состояний | |
BRPI0607084A2 (pt) | uso de um composto 11-desóxiprostaglandina, composição compreendendo o mesmo, e composto | |
BR112015018047A2 (pt) | composições estáveis que compreendem heparinoide, anestésico de ação aguda e tampão | |
BR112012019920A2 (pt) | derivados de piridazina úteis como agonístas de canabinoide-2. | |
BRPI1010941A2 (pt) | métodos para promover a formação de anel de dinamina e/ou a manutenção de anéis de dinamina em uma célula, para profilaxia ou tratamento de uma doença ou condição renal, e de disfunção dos podócitos, para induzir adesões focais e/ou citoesuqleto de actina em uma célula, e de triagem de uma agente de teste para uso como um estabilizador de anel de dinamina, estabilizador de anel de dinamina, e, uso de pelo menos um estabilizador de anel de dinamina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |